IRS Gene Polymorphisms in Turkish Patients with Late-onset Alzheimer's Disease

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2025 Feb 15

PMID 39954137

Authors

Hulya Ozkan

Mustafa Yildiz

Ayten Ustundag

Ismail Kara

Baburhan Guldiken

Necdet Sut

Tammam Sipahi

Affiliations

Soon will be listed here.

Abstract

Background: Factors that cause changes in insulin signaling in the brain are thought to affect the synaptic plasticity and accelerate the process of brain aging and neurodegeneration. Insulin receptor substrate (IRS) molecules are key mediators in insulin signaling. The aim of the current study is to determine whether there is an association between IRS gene polymorphisms, which are critical for insulin signaling, and the late-onset Alzheimer's disease in Turkish patients.

Methods And Results: Demographic and clinical characteristics of 115 patients with late-onset Alzheimer's disease (age of onset ≥ 65 years) and 107 age-matched control subjects were obtained. DNAs were isolated from patient and control groups, IRS-1 and IRS-2 gene polymorphisms were investigated and genotyped according to the PCR-RFLP method. No statistically significant difference was observed in the genotypes for IRS-1 Gly972Arg (rs1801278) (p = 0.499) and IRS-2 Gly1057Asp (rs1805097) polymorphism between late-onset Alzheimer's disease patients and controls (p = 0.658). However, when the compliance of IRS-2 polymorphism with Hardy- Weinberg distribution was tested, in the case-control comparison, G allele frequency of IRS-2 polymorphisms was significantly higher in the patient population than in the control group in the Turkish population of the Thrace region.

Conclusions: Despite the potential role of insulin resistance and hyperinsulinemia in the development of Alzheimer's disease, we did not find any association between polymorphism of the IRS-1 and IRS-2 genes and late-onset Alzheimer's disease. However, compared to the healthy subjects, Gly/Gly genotypes and the G allele in the IRS-2 were significantly more frequent in patients with late-onset Alzheimer's disease.

References

Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y . Memory improvement following induced hyperinsulinemia in Alzheimer's disease. Neurobiol Aging. 1996; 17(1):123-30. DOI: 10.1016/0197-4580(95)02002-0. View

Kullmann S, Heni M, Hallschmid M, Fritsche A, Preissl H, Haring H . Brain Insulin Resistance at the Crossroads of Metabolic and Cognitive Disorders in Humans. Physiol Rev. 2016; 96(4):1169-209. DOI: 10.1152/physrev.00032.2015. View

Biessels G, Staekenborg S, Brunner E, Brayne C, Scheltens P . Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2005; 5(1):64-74. DOI: 10.1016/S1474-4422(05)70284-2. View

Fishel M, Watson G, Montine T, Wang Q, Green P, Kulstad J . Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Arch Neurol. 2005; 62(10):1539-44. DOI: 10.1001/archneur.62.10.noc50112. View

Matsuzaki T, Sasaki K, Tanizaki Y, Hata J, Fujimi K, Matsui Y . Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study. Neurology. 2010; 75(9):764-70. DOI: 10.1212/WNL.0b013e3181eee25f. View

Profenno L, Porsteinsson A, Faraone S . Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry. 2009; 67(6):505-12. DOI: 10.1016/j.biopsych.2009.02.013. View

Ahmed S, Mahmood Z, Zahid S . Linking insulin with Alzheimer's disease: emergence as type III diabetes. Neurol Sci. 2015; 36(10):1763-9. DOI: 10.1007/s10072-015-2352-5. View

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E . Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34(7):939-44. DOI: 10.1212/wnl.34.7.939. View

Bedse G, Di Domenico F, Serviddio G, Cassano T . Aberrant insulin signaling in Alzheimer's disease: current knowledge. Front Neurosci. 2015; 9:204. PMC: 4468388. DOI: 10.3389/fnins.2015.00204. View

10.

Sedzikowska A, Szablewski L . Insulin and Insulin Resistance in Alzheimer's Disease. Int J Mol Sci. 2021; 22(18). PMC: 8472298. DOI: 10.3390/ijms22189987. View

11.

Fallucca F, Dalfra M, Sciullo E, Masin M, Buongiorno A, Napoli A . Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy. Metabolism. 2006; 55(11):1451-6. DOI: 10.1016/j.metabol.2006.06.004. View

12.

Florez J, Sjogren M, Burtt N, Orho-Melander M, Schayer S, Sun M . Association testing in 9,000 people fails to confirm the association of the insulin receptor substrate-1 G972R polymorphism with type 2 diabetes. Diabetes. 2004; 53(12):3313-8. DOI: 10.2337/diabetes.53.12.3313. View

13.

Zhao H, Liu S, Long M, Peng L, Deng H, You Y . Arg972 insulin receptor substrate-1 polymorphism and risk and severity of rheumatoid arthritis. Int J Rheum Dis. 2014; 19(2):141-5. DOI: 10.1111/1756-185X.12366. View

14.

Christopoulos P, Mastorakos G, Gazouli M, Deligeoroglou E, Katsikis I, Diamanti-Kandarakis E . Study of association of IRS-1 and IRS-2 genes polymorphisms with clinical and metabolic features in women with polycystic ovary syndrome. Is there an impact?. Gynecol Endocrinol. 2010; 26(9):698-703. DOI: 10.3109/09513591003649823. View

15.

Cayan F, Ertunc D, Aras-Ates N, Ayaz L, Akbay E, Karakas S . Association of G1057D variant of insulin receptor substrate-2 with endometriosis. Fertil Steril. 2009; 94(5):1622-6. DOI: 10.1016/j.fertnstert.2009.09.023. View

16.

Esposito D, Verginelli F, Toracchio S, Mammarella S, De Lellis L, Vanni C . Novel insulin receptor substrate 1 and 2 variants in breast and colorectal cancer. Oncol Rep. 2013; 30(4):1553-60. PMC: 3810354. DOI: 10.3892/or.2013.2626. View

17.

Zhang H, Wang A, Ma H, Xu Y . Association between insulin receptor substrate 1 Gly972Arg polymorphism and cancer risk. Tumour Biol. 2013; 34(5):2929-36. DOI: 10.1007/s13277-013-0855-3. View

18.

Wang W, Yang L, Tan L, Wu X, Jiang B, Shen X . Arg972 insulin receptor substrate-1 polymorphism and risk and severity of Alzheimer's disease. J Clin Neurosci. 2014; 21(7):1233-7. DOI: 10.1016/j.jocn.2013.09.028. View

19.

Coon K, Myers A, Craig D, Webster J, Pearson J, Lince D . A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. J Clin Psychiatry. 2007; 68(4):613-8. DOI: 10.4088/jcp.v68n0419. View

20.

Ferreira L, Fernandes C, Vieira M, De Felice F . Insulin Resistance in Alzheimer's Disease. Front Neurosci. 2018; 12:830. PMC: 6277874. DOI: 10.3389/fnins.2018.00830. View